Transdermal Drug Delivery Systems Market Making Great Strides By Top Companies like Novartis AG, Johnson & Johnson, Mylan N.V, Boehringer Ingelheim GmbH, Bayer, Bristol-Myers Squibb Company, GlaxoSmithKline plc, & Many Others

Global Transdermal Drug Delivery Systems Market was valued at $32,516 million in 2016, and is estimated to reach $61,689 million by 2023, growing at a CAGR of 9.5% during the study period. Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous, and transmucosal routes, wherein the drugs are delivered through the skin for therapeutic use. Rise in geriatric population and upsurge in number of patients suffering from chronic disorders are expected to drive the market growth. Moreover, increase in adoption of third-generation transdermal drug delivery systems, such as iontophoresis, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/485

Rise in Incidence of Chronic Disorders and Geriatric Population

As per the estimates of the World Health Organization, globally, more than 422 million people were diagnosed with diabetes in 2014. In addition, rise in geriatric population poses risk for increase in incidence of diabetes. For instance, aged people (>65 years of age) are more susceptible to Type 2 diabetes.

Recent Advancements

The market has witnessed development of new adhesives, molecular absorption enhancers, and penetration enhancers that are expected to enhance skin permeability, resulting in expansion of the range of drugs that are expected to be delivered through transdermal route. For instance, new technology, such as micro needle-enhanced delivery, helps easy transportation of drug across the skin without the sensation of pain.

Transdermal drug delivery systems are used to deliver drug through intact skin at a controlled rate into the systemic circulation. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as hypertension, diabetes, and angina, are expected to drive the market growth. Moreover, surge in adoption of new delivery system technologies, such as ultrasound, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.

The passive system segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of chronic disorders, such as hypertension. The active system segment is expected to register highest CAGR of 12.8% during the forecast period.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/485

The major companies profiled in the report includes

• Novartis AG,
• Johnson & Johnson,
• Mylan N.V.,
• Boehringer Ingelheim GmbH,
• Bayer AG,
• Bristol-Myers Squibb Company,
• GlaxoSmithKline plc.,
• Acrux Limited,
• Echo Therapeutics, Inc., and
• Endo Pharmaceuticals Inc.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Rising geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Rise in adoption of third-generation delivery systems
3.4.2. Restraints
3.4.2.1. Side-effects of the systems
3.4.3. Opportunities
3.4.3.1. Emerging nations

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/transdermal-drug-delivery-systems-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.